Objective area measurement technique for choroidal neovascularization from fluorescein angiography

Microvascular Research

Volumn 91, Issue , 2014, Pages 1-7

  Guthrie, Micah J ^a   Osswald, Christian R ^a   Valio, Nicole L ^a   Mieler, William F ^b   Kang Mieler, Jennifer J ^a  

^a Illinois Institute of Technology   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE SODIUM PHOSPHATE; TRIAMCINOLONE ACETONIDE;

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUCH MEMBRANE; COMPARATIVE ANATOMY; CONFOCAL SCANNING LASER OPHTHALMOSCOPE; CONTROLLED STUDY; FUNDUS CAMERA; HISTOGRAM; HISTOPATHOLOGY; HYDROGEL; IMAGE ANALYSIS; IMAGING SOFTWARE; MALE; MULTI OTSU THRESHOLDING TECHNIQUE; NONHUMAN; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; RAT; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; SUSPENSION;

RATTUS; RODENTIA;

ANIMALS; BRUCH MEMBRANE; CHOROIDAL NEOVASCULARIZATION; DEXAMETHASONE; FLUORESCEIN; FLUORESCEIN ANGIOGRAPHY; HUMANS; HYDROGELS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTRAVITREAL INJECTIONS; LASERS; MACULAR DEGENERATION; MALE; NANOSPHERES; RATS; RATS, LONG-EVANS; TRIAMCINOLONE ACETONIDE;

EID: 84892365869     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.11.005     Document Type: Article

References (32)

1. Augustin A.J., Puls S., Offermann I. Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone. Retina 2007, 27:133-140.
2. Beer P.M., Bakri S.J., Singh R.J., Liu W., Peters G.B., Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003, 110:681-688.
3. Brown D.M., Michels M., Kaiser P.K., Heier J.S., Sy J.P., Ianchulev T. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR Study. Ophthalmology 2009, 116:57-65.
4. Challa J.K., Gillies M.C., Penfold P.L., Gyory J.F., Hunyor A.B.L., Billson F.A. Exudative macular degeneration and intravitreal triamcinolone: 18month follow up. Aust. N. Z. J. Ophthalmol. 1998, 26:277-281.
5. Ciulla T.A., Criswell M.H., Danis R.P., Fronheiser M., Yuan P., Cox T.A., Csaky K.G., Robinson M.R. Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants. Br. J. Ophthalmol. 2003, 87:1032-1037.
6. Ciulla T.A., Criswell M.H., Danis R.P., Hill T.E. Intravitreal triamcinolone acetonide Inhibits choroidal neovascularization in a laser-treated rat model. Arch. Ophthalmol. 2001, 119:399-404.
7. Dobi E.T., Puliafito C.A., Destro M. A new model of experimental choroidal neovascularization in the rat. Arch. Ophthalmol. 1989, 107:264-269.
8. Edelman J.L., Castro M.R. Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp. Eye Res. 2000, 71:523-533.
9. Faghih F., Smith M. Combining spatial and scale-space techniques for edge detection to provide a spatially adaptive wavelet-based noise filtering algorithm. IEEE Trans. Image Process. 2002, 11:1062-1071.
10. Frank R.N., Das A., Weber M.L. A model of subretinal neovascularization in the pigmented rat. Curr. Eye Res. 1989, 8:239-247.
11. Giani A., Thanos A., Roh M.I., Connolly E., Trichonas G., Kim I., Gragoudas E., Vavvas D., Miller J.W. In vivo evaluation of laser-induced choroidal neovascularization using spectral-domain optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 2011, 52:3880-3887.
12. Green W.R., Wilson D.J. Choroidal neovascularization. Ophthalmology 1986, 93:1169-1176.
13. Grossniklaus H.E., Kang S.J., Berglin L. Animal models of choroidal and retinal neovascularization. Prog. Retin. Eye Res. 2010, 29:500-519.
14. Herrero-Vanrell R., Cardillo J.A., Kuppermann B.D. Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin. Ophthalmol. 2011, 5:139-146.
15. Kang-Mieler J.J., Jiang B., Perez-Luna V., Brey E., Mieler W.F. PLGA nanospheres encapsulated within thermo-responsive hydrogel for ocular delivery of dexamethasone sodium phosphate, in: Nanomedicine, Nanopharmaceuticals, Tissue Bioengineering, Regenerative Medicine, and Nanodiagnostics. Ophthalmol. Vis. Sci. 2011, Fort Lauderdale, FL.
16. Kang-Mieler J.J., Osswald C.R., Guthrie M.J., Mieler W.F. Efficacy of dexamethasone sodium phosphate nanospheres within thermo-responsive hydrogel treatment in a laser induced choroidal neovascularization animal model, in: AMD clinical and translational research. Invest. Ophthalmol. Vis. Sci. 2012, Fort Lauderdale, FL.
17. Kim S.J., Toma H.S. Inhibition of choroidal neovascularization by intravitreal ketorolac. Arch. Ophthalmol. 2010, 128:596-600.
18. Klein R., Klein B.E.K., Knudtson M.D., Meuer S.M., Swift M., Gangnon R.E. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye study. Ophthalmology 2007, 114:253-262.
19. Krzystolik M.D., Afshari M.A., Adamis A.P., Gaudreault J., Gragoudas E.S., Michaud N.A., Li W., Connolly E., O'Neill C.A., Miller J.W. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch. Ophthalmol. 2002, 120:338-346.
20. Kuroki A.M., Bhutto I.A., Kitaoka T., Amemiya T. Natural course of experimental choroidal neovascularization: three-dimensional study with corrosion cast and scanning electron microscope. Ophthalmic Res. 2002, 34:200-205.
21. Liao P.-S., Chen T.-S., Chung P.-C. A fast algorithm for multilevel thresholding. J. Inf. Sci. Eng. 2001, 17:713-728.
22. Lund-Andersen H. Mechanisms for monitoring changes in retinal status following therapeutic intervention in diabetic retinopathy. Surv. Ophthalmol. 2002, 47(Suppl. 2):S270-S277.
23. Miller H., Miller B., Ishibashi T., Ryan S.J. Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest. Ophthalmol. Vis. Sci. 1990, 31:899-908.
24. Ming Y., Algvere P.V., Odergren A., Berglin L., van der Ploeg I., Seregard S., Kvanta A. Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina. Invest. Ophthalmol. Vis. Sci. 2004, 45:1969-1974.
25. Otsu N. A threshold selection method from gray-level histograms. IEEE Trans. Syst. Man Cybern. 1979, 9:62-66.
26. Patel N.B., Luo X., Wheat J.L., Harwerth R.S. Retinal nerve fiber layer assessment: area versus thickness measurements from elliptical scans centered on the optic nerve. Invest. Ophthalmol. Vis. Sci. 2011, 52:2477-2489.
27. Rechtman E., Allen V.D., Danis R.P., Pratt L.M., Harris A., Speicher M.A. Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. Am J. Ophthalmol. 2003, 136:739-741.
28. Rosenfeld P.J., Brown D.M., Heier J.S., Boyer D.S., Kaiser P.K., Chung C.Y., Kim R.Y. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 2006, 355:1419-1431.
29. Takahashi H., Yanagi Y., Tamaki Y., Uchida S., Muranaka K. COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model. Biochem. Biophys. Res. Commun. 2004, 325:461-466.
30. Toma H.S., Barnett J.M., Penn J.S., Kim S.J. Improved assessment of laser-induced choroidal neovascularization. Microvasc. Res. 2010, 80:295-302.
31. Turturro S.B., Guthrie M.J., Appel A.A., Drapala P.W., Brey E.M., Pérez-Luna V.H., Mieler W.F., Kang-Mieler J.J. The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function. Biomaterials 2011, 32:3620-3626.
32. Yu H.G., Liu X., Kiss S., Connolly E., Gragoudas E.S., Michaud N.A., Bulgakov O.V., Adamian M., DeAngelis M.M., Miller J.W., Li T., Kim I.K. Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1. Invest. Ophthalmol. Vis. Sci. 2008, 49:2599-2605.